Page 7 - SDIR5 Abstract book 21 12 2021.

PROGRAMME

03.12.2021. Virtual event 09.00 – 17.30

09.00 – 09.05 Congress welcome and opening. SDIR President Mirjana Branković-
Magić
09.05 – 09.30 EACR Plenary lecture – EACR President Caroline Dive. Liquid biopsies in lung
cancer. University of Manchester, Manchester, UK

09.30 - 09.40 Discussion

09.40 – 11.05 Session: Advances in solid tumor research

Chairs: Caroline Dive and Milena Čavić

09.40 – 10.00 Remond J.A. Fijneman. ctDNA biomarker detection in patients with colorectal
cancer. The Netherlands Cancer Institute, Amsterdam, Netherlands
10.00 – 10.20 Gunes Esendagli. Mesenchymal properties and immune checkpoint pathways in
small cell lung cancer (SCLC) stem cells. Hacettepe University Cancer Institute,
Ankara, Turkey

10.20 – 10.50 Short talks selected from SDIR member PIs of The Program for Excellent Projects
of Young Researchers (PROMIS) of the Science Fund of the Republic of Serbia

10.20 – 10.30 Miljana Tanić. Tracking systemic therapy resistance of lung and colorectal cancer
through targeted NGS analysis of genetic and epigenetic variants in liquid
biopsies. Institute of Oncology and Radiology of Serbia, Serbia

10.30 – 10.40 Aleksandra Nikolić. Cancer biosensors based on gene regulatory elements.
Institute of Molecular Genetics and Genetic Engineering, Serbia

10.40 – 10.50 Jelena Grahovac. Drug repurposing in pancreatic ductal adenocarcinoma.
Institute of Oncology and Radiology of Serbia, Serbia

10.50 – 11.05 Discussion

11.05 – 11.15 Break

11.15 – 12.40 Session: Cancer and metabolism

Chair: Milica Pešić

11.15 – 11.35 Liang Li. An antibody drug conjugate-like agent DTLL sensitizes gemcitabine
efficacy in pancreatic cancer based on SMAD4 profiles. Institute of Medicinal
Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical
College, Beijing, China

I
SDIR – 5